Blog / Archives
Biotech Meltdown: Financial Metrics Offer Few Clues For What is Next
Biotech Meltdown: Numbers Don't Mean Much Until We See New Product Growth We are almost through the earnings season and despite good results most biotech stocks tanked again today.The reason you...
Biotech Bear Market Looking For Relief From Q3 Large Cap Growth…Update-3
Update-3... 10/28 9:30 am... No Relief From Earnings- Biotech Stocks Get Crushed By More Pricing Commentary on Earnings Calls Amgen (AMGN) down 11% on pipeline, revenue growth, Enbrel pricing...
BIO Investor Forum 2016 #2:”Liquid Biopsy” Tests for Cancer…Update-1
CLIA Labs Offer Liquid Biopsy Tests for Cancer and Precision Medicine We attended presentations from two emerging companies developing molecular diagnostics platforms focused in cancer.Their mission...
BIO Investor Forum 2016 #1: Translating Microbiome Research Into Treatments
Microbiomes: A New Paradigm for Drug Discovery? Focus: Drugs From Gut Bacteria You may have read a few articles about the impact of the microbiomes and their impact on diets, digestion and nutrition...
BIO Investor Forum October 18-19, 2016… Preview
BIO Investor Forum 2016 We will be attending the BIO Investor Forum beginning Tuesday October 18 for two days. Last year the meeting was excellent for coverage of small cap biotech companies and...
Biotechnology Bear Market: Trends to Watch for a 2016 Q4 Rally…Updates
Update-1... 10/14...2:30p EDT Ariad Pharmaceuticals (ARIA) Drops 8.25% to $12 on Senator Bernie Sanders Criticism of Drug Pricing; Sanders was also on Bill Maher (HBO) XBI down 2.25% just below...
Illumina (ILMN) Misses Revenue Forecast Causing Collateral Damage to Biotechs
Update-1 Biotechs Sinking Again ...IBB down 2.48%, ILMN down another 2% Related sequencing stocks: FMI down 1.75%, PACB flat at $8.40 Illumina (ILMN) Shares Crash on Revenue Miss Illumina (ILMN)...
Biotech Stocks Recovering from Last Week’s Free Fall: XBI…Update-2
Green Tape Today Shows Resilience-- 10/10/16 ESMO Cancer Congress 4%+ Up movers: AGIO ARIA BLUE CLVS LGND PBYI TSRO etc. XBI up 2.39% More Bad Clinical News for Biotech:ALNY,CLVS The XBI lost 3.2%...
Rayno 2016 Life Science Portfolio Update…BLUE,IBB…Update-2
Update-1... See Caution 9/29 Update-2...See Rayno Biobeat for updates after Trump Rally. For overweighting biotechs in a portfolio consider XBI instead of IBB to get mid and small cap exposure....
Biotech Stocks Pause at Resistance: IBB…Update-2…Caution
Update-2... 9/29 Caution on Biotech-Major Sell-Off with IBB off 3.12% The market had a bad day today hit by Wells Fargo (WFC) Congressional hearings and paranoia about Deutsche Bank AG (DB)....